To view this email as a web page, click here.
 
FDA clears novel diabetes, tropical disease treatments
FDA approved the first interoperable insulin pump, as well as the only FDA-approved drug for treatment of a neglected tropical disease.
Read more
 
Opinion: The need for value-based PBMs
From our sister brand, Managed Healthcare Executive: The concept of value-based care has begun to percolate through hospitals, doctor’s offices, and even Medicare, the behemoth of US healthcare. It’s time for this principle to be embraced by PBMs.
Read more
 
Top barriers to biosimilar approval and adoption in the US
From our sister brand, Managed Healthcare Executive: The biosimilar market is flourishing in Europe—why aren’t we seeing similar gains in the US?
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.